Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Revenue	$ 63,474	$ 7,803
Costs and expenses:
Cost of revenue	5,441	857
Research and development:
Noncash compensation	2,452	1,584
Other research and development	30,270	14,286
Total research and development	32,722	15,870
Selling, general and administrative:
Noncash compensation	6,887	5,240
Other selling, general and administrative	27,694	22,828
Total selling, general and administrative	34,581	28,068
Total costs and expenses	72,744	44,795
Operating loss	(9,270)	(36,992)
Other expense (income):
Interest expense	2,288	2,844
Other income	(880)	(604)
Total other expense (income), net	1,408	2,240
Net loss before taxes	(10,678)	(39,232)
Income taxes	29
Net loss	$ (10,707)	$ (39,232)
Basic and diluted net loss per common share (in dollars per share)	$ (0.07)	$ (0.28)
Weighted-average shares used in computing basic and diluted net loss per common share (in shares)	146,209,213	140,312,269
Product [Member]
Revenue:
Revenue	$ 50,488	$ 7,765
License [Member]
Revenue:
Revenue	$ 12,986	$ 38